JENNINGS POLICY STRATEGIES for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER JENNINGS | — |
Medicare/Medicaid MMM
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER JENNINGS | — |
Pharmacy PHA
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER JENNINGS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.